{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:42:49Z","timestamp":1791592969574,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Expert Team Program of the Wuxi Taihu Talent Plan","award":["THRC-TD-YXYXK-2021"],"award-info":[{"award-number":["THRC-TD-YXYXK-2021"]}]},{"name":"Specialized Disease Queue Project of Wuxi Medical Center, Nanjing Medical University","award":["WMCC202402"],"award-info":[{"award-number":["WMCC202402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Depression, anxiety and apathy are the most common emotional symptoms in patients with Parkinson\u2019s disease (PD). However, the association between these symptoms and brain iron deposition remains unclear. This study aimed to systematically evaluate the strength of association between brain iron deposition and anxiety, depression, and apathy in PD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic search was conducted in PubMed, Embase, and Web of Science databases from their inception to September 2025 to include eligible observational studies investigating the association between brain iron deposition and anxiety, depression, or apathy in PD patients. Heterogeneity among studies was assessed via Cochran\u2019s Q test and I\n                      <jats:sup>2<\/jats:sup>\n                      statistic, and a fixed-effects or random-effects model was selected to pool effect sizes based on the heterogeneity level. Subgroup analyses (stratified by outcome measures and brain regions), sensitivity analysis, and publication bias assessment (Egger\u2019s test and Begg\u2019s test) were conducted to verify the robustness of the results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 8 cross-sectional studies were finally included, with a total sample size of 855. The overall risk of bias of the included studies was manageable. Meta-analysis results showed a significant association between brain iron deposition and the occurrence of anxiety and depression in PD patients, with a pooled standardized mean difference (SMD) of 0.95 (95% confidence interval [95%CI]: 0.73\u20131.17). The results of the subgroup analysis showed that the results of the depression subgroup were highly stable (I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200925%). In brain region stratification, iron deposition in the substantia nigra (SMD\u2009=\u20091.01, 95%CI: 0.82\u20131.19) and general subcortical nuclei (SMD\u2009=\u20090.53, 95%CI: 0.23\u20130.84) were significantly associated with emotional symptoms, and the heterogeneity among the subgroups was low. Only 1 study was included in the apathy subgroup or the cortical subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Brain iron deposition in PD patients is significantly associated with the occurrence of anxiety and depression, with the substantia nigra and general subcortical nuclei as the core associated brain regions. These findings can provide potential biomarkers for the early prediction and targeted intervention of emotional symptoms in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04866-w","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:05:27Z","timestamp":1775469927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between iron deposition and emotional disorder in Parkinson\u2019s patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Kaidong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binfen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"3","key":"4866_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000531422","volume":"32","author":"EKJ Pauwels","year":"2023","unstructured":"Pauwels EKJ, Boer GJ. Parkinson\u2019s disease: a tale of many players. Med Princ Pract. 2023;32(3):155\u201365.","journal-title":"Med Princ Pract"},{"key":"4866_CR2","doi-asserted-by":"publisher","first-page":"1664934","DOI":"10.3389\/fnagi.2025.1664934","volume":"17","author":"JF Baizabal-Carvallo","year":"2025","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R. Top motor and non-motor complaints in patients with Parkinson\u2019s disease. Front Aging Neurosci. 2025;17:1664934.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"4866_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4103\/neurol-india.Neurol-India-D-25-00573","volume":"73","author":"S Ahsan","year":"2025","unstructured":"Ahsan S, Mehta S, Chakravarti K, Ray S, Grover S, Saharan R, et al. Non-motor symptoms in Parkinson\u2019s disease and their impact on quality of life: a cross-sectional study. Neurol India. 2025;73(6):1219\u201325.","journal-title":"Neurol India"},{"key":"4866_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11060771","author":"F Chuquil\u00edn-Arista","year":"2021","unstructured":"Chuquil\u00edn-Arista F, \u00c1lvarez-Avell\u00f3n T, Men\u00e9ndez-Gonz\u00e1lez M. Impact of depression and anxiety on dimensions of health-related quality of life in subjects with Parkinson\u2019s disease enrolled in an association of patients. Brain Sci. 2021. https:\/\/doi.org\/10.3390\/brainsci11060771.","journal-title":"Brain Sci"},{"key":"4866_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050714","author":"P Dusek","year":"2022","unstructured":"Dusek P, Hofer T, Alexander J, Roos PM, Aaseth JO. Cerebral iron deposition in neurodegeneration. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050714.","journal-title":"Biomolecules"},{"issue":"6","key":"4866_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/CM9.0000000000003167","volume":"138","author":"J Jin","year":"2025","unstructured":"Jin J, Su D, Zhang J, Lam JST, Zhou J, Feng T. Iron deposition in subcortical nuclei of Parkinson\u2019s disease: a meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies. Chin Med J (Engl). 2025;138(6):678\u201392.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4866_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10571-024-01459-4","volume":"44","author":"W Zeng","year":"2024","unstructured":"Zeng W, Cai J, Zhang L, Peng Q. Iron deposition in Parkinson\u2019s disease: a mini-review. Cell Mol Neurobiol. 2024;44(1):26.","journal-title":"Cell Mol Neurobiol"},{"key":"4866_CR8","first-page":"g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ (Clinical research ed). 2015;350:g7647.","journal-title":"BMJ (Clinical research ed)"},{"key":"4866_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2018.01.008","volume":"386","author":"H An","year":"2018","unstructured":"An H, Zeng X, Niu T, Li G, Yang J, Zheng L, et al. Quantifying iron deposition within the substantia nigra of Parkinson\u2019s disease by quantitative susceptibility mapping. J Neurol Sci. 2018;386:46\u201352.","journal-title":"J Neurol Sci"},{"key":"4866_CR10","doi-asserted-by":"publisher","first-page":"1116516","DOI":"10.3389\/fnagi.2023.1116516","volume":"15","author":"K Chen","year":"2023","unstructured":"Chen K, Zhang L, Mao H, Chen K, Shi Y, Meng X, et al. The impact of iron deposition on the fear circuit of the brain in patients with Parkinson\u2019s disease and anxiety. Front Aging Neurosci. 2023;15:1116516.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"4866_CR11","doi-asserted-by":"publisher","first-page":"e25303","DOI":"10.1002\/jnr.25303","volume":"102","author":"Y Fan","year":"2024","unstructured":"Fan Y, Li X, Ma J, Yang D, Liang K, Shen Y, et al. Increased plasma lipocalin-2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson\u2019s disease. J Neurosci Res. 2024;102(2):e25303.","journal-title":"J Neurosci Res"},{"issue":"7","key":"4866_CR12","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.21037\/qims-24-168","volume":"14","author":"W Guo","year":"2024","unstructured":"Guo W, Zhang D, Sun J, Chen L, Wu T, Xu E. Quantitative susceptibility mapping of subcortical iron deposition in Parkinson disease and multiple system atrophy: clinical correlations and diagnostic implications. Quant Imaging Med Surg. 2024;14(7):4464\u201374.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"4866_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jnnp-2019-322042","volume":"91","author":"GEC Thomas","year":"2020","unstructured":"Thomas GEC, Leyland LA, Schrag AE, Lees AJ, Acosta-Cabronero J, Weil RS. Brain iron deposition is linked with cognitive severity in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2020;91(4):418\u201325.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4866_CR14","doi-asserted-by":"publisher","first-page":"e16546","DOI":"10.1111\/ene.16546","volume":"32","author":"J Wen","year":"2025","unstructured":"Wen J, Duanmu X, Tan S, Wu C, Peng X, Qin J, et al. Spatiotemporal neurodegeneration of the substantia nigra and its connecting cortex and subcortex in Parkinson\u2019s disease. Eur J Neurol. 2025;32(1):e16546.","journal-title":"Eur J Neurol"},{"issue":"12","key":"4866_CR15","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.21037\/qims-23-267","volume":"13","author":"Y Yan","year":"2023","unstructured":"Yan Y, Wang Z, Wei W, Yang Z, Guo L, Wang Z, et al. Correlation of brain iron deposition and freezing of gait in Parkinson\u2019s disease: a cross-sectional study. Quant Imaging Med Surg. 2023;13(12):7961\u201372.","journal-title":"Quant Imaging Med Surg"},{"issue":"9","key":"4866_CR16","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.21037\/qims-2024-2626","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Chen K, Zhi Y, Ji W, Shi G, You Y, et al. Association between brain iron deposition and pure apathy in Parkinson\u2019s disease: a cross-sectional quantitative susceptibility mapping imaging study. Quant Imaging Med Surg. 2025;15(9):8292\u2013308.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"4866_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/13872877251375432","volume":"108","author":"F Casanova","year":"2025","unstructured":"Casanova F, Tian Q, Williamson DS, Lucas MR, Zweibaum D, Ding J, et al. Predictors of MRI-estimated brain iron deposition in dementia and Parkinson\u2019s disease-associated subcortical regions: genetic and observational analysis in UK Biobank. J Alzheimers Dis. 2025;108(1):107\u201318.","journal-title":"J Alzheimers Dis"},{"key":"4866_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12111997","author":"Q Wu","year":"2023","unstructured":"Wu Q, Ren Q, Meng J, Gao WJ, Chang YZ. Brain iron homeostasis and mental disorders. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12111997.","journal-title":"Antioxidants"},{"issue":"5","key":"4866_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3171\/2025.3.JNS241544","volume":"143","author":"P Kuru Bektasoglu","year":"2025","unstructured":"Kuru Bektasoglu P, Ghare A, Elias C, Firat Z, Gungor A. Afferent and efferent fiber systems of the human amygdala: anatomical, pathophysiological, and clinical significance. J Neurosurg. 2025;143(5):1202\u201316.","journal-title":"J Neurosurg"},{"issue":"1","key":"4866_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-023-02875-x","volume":"20","author":"T Zeng","year":"2023","unstructured":"Zeng T, Li J, Xie L, Dong Z, Chen Q, Huang S, et al. Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression. J Neuroinflammation. 2023;20(1):212.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"4866_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41401-023-01153-z","volume":"45","author":"QQ Shen","year":"2024","unstructured":"Shen QQ, Jv XH, Ma XZ, Li C, Liu L, Jia WT, et al. Cell senescence induced by toxic interaction between \u03b1-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson\u2019s disease. Acta Pharmacol Sin. 2024;45(2):268\u201381.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"4866_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.biopsych.2006.06.004","volume":"60","author":"SL Rauch","year":"2006","unstructured":"Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research\u2013past, present, and future. Biol Psychiatry. 2006;60(4):376\u201382.","journal-title":"Biol Psychiatry"},{"key":"4866_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jpsychires.2025.09.031","volume":"191","author":"L Gu","year":"2025","unstructured":"Gu L, Zhang P, Wang Y, Zhu Y, Li H, Shu H. Prevalence, contributing factors, and clinical impact of apathy in Parkinson\u2019s disease. J Psychiatr Res. 2025;191:382\u201392.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"4866_CR24","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3233\/JPD-223372","volume":"12","author":"J Wen","year":"2022","unstructured":"Wen J, Guo T, Wu J, Bai X, Zhou C, Wu H, et al. Nigral iron deposition influences disease severity by modulating the effect of Parkinson\u2019s disease on brain networks. J Parkinsons Dis. 2022;12(8):2479\u201392.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"4866_CR25","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1002\/hbm.22928","volume":"36","author":"N He","year":"2015","unstructured":"He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z, et al. Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping. Hum Brain Mapp. 2015;36(11):4407\u201320.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"4866_CR26","first-page":"9","volume":"10","author":"EC Lauterbach","year":"1997","unstructured":"Lauterbach EC, Jackson JG, Wilson AN, Dever GE, Kirsh AD. Major depression after left posterior globus pallidus lesions. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10(1):9\u201316.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"4866_CR27","doi-asserted-by":"crossref","unstructured":"Li W, Gao B, Du W, Jiang Y, Yang J, Hu R, Liu Y, Liu N, Zhang Y, Song Q, et al. Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson\u2019s disease patients with type 2 diabetes mellitus. Front Aging Neurosci. 2022;14:975390.","DOI":"10.3389\/fnagi.2022.975390"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04866-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:31:53Z","timestamp":1781645513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04866-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4866"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04866-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}